ARCHIVES

Risk-Benefit Analysis Advised Prior To Hormone Therapy

This article is from The Cancer Letter archive.

Vol. 33 No. 8 | August 27, 2010

Download PDF Visit The Full Archive

Related Articles

Skipper’s Impact: Drugs Curing 40,000 a Year

March 27, 1981

NCI Cooperative Group, Cancer Center Trials Listed

February 29, 2008

In Brief: Philadelphia Chromosome Discoverer Hungerford Dead; Oregon Recruits Scientists

November 12, 1993

NCI’s Frei & Freireich era Lauded As Researchers Receive First NIH Distinguished Alumni Award

September 14, 1990

Britol-Meyers Holds Taxol Briefings, Outlines Timetable

July 5, 1991

Researchers Link Obesity With 34% Higher Death Risk In Pre-Menopausal Women

May 30, 2014